Whitnell & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$25K Hold
500
0.01% 230
2019
Q3
$24K Hold
500
0.01% 228
2019
Q2
$24K Hold
500
0.01% 206
2019
Q1
$24K Hold
500
0.01% 209
2018
Q4
$22K Hold
500
0.01% 203
2018
Q3
$27K Hold
500
0.01% 197
2018
Q2
$24K Hold
500
0.01% 201
2018
Q1
$31K Hold
500
0.01% 192
2017
Q4
$31K Hold
500
0.01% 189
2017
Q3
$33K Hold
500
0.01% 187
2017
Q2
$39K Hold
500
0.02% 180
2017
Q1
$41K Hold
500
0.02% 183
2016
Q4
$36K Hold
500
0.02% 187
2016
Q3
$39K Sell
500
-400
-44% -$32.3K 0.01% 192
2016
Q2
$70K Hold
900
0.02% 174
2016
Q1
$74K Hold
900
0.03% 169
2015
Q4
$80K Hold
900
0.03% 169
2015
Q3
$69K Hold
900
0.03% 167
2015
Q2
$75K Hold
900
0.03% 171
2015
Q1
$81K Hold
900
0.03% 161
2014
Q4
$73K Hold
900
0.03% 175
2014
Q3
$67K Hold
900
0.03% 178
2014
Q2
$62K Hold
900
0.03% 178
2014
Q1
$63K Hold
900
0.03% 173
2013
Q4
$60K Hold
900
0.03% 177
2013
Q3
$47K Hold
900
0.02% 184
2013
Q2
$42K Buy
+900
New +$41.1K 0.02% 198

Other funds holding CAH

Whitnell & Co's CAH Position: Q4 2019 in Review

Whitnell & Co held its Cardinal Health (CAH) position steady in Q4 2019 at 500 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #230.

Whitnell & Co first reported a position in CAH in Q2 2013 and has held it in 27 quarters since. The position peaked at $81K in Q1 2015. 713 funds tracked by Wall St. Rank hold CAH as of Q4 2019.

  • Whitnell & Co held 500 shares of Cardinal Health worth $25K as of Q4 2019.
  • Whitnell & Co left its Cardinal Health share count unchanged in Q4 2019.
  • Cardinal Health made up 0.01% of Whitnell & Co's portfolio in Q4 2019, its #230 holding.
  • Whitnell & Co first reported a position in Cardinal Health in Q2 2013 and has held it in 27 quarters since.
  • Whitnell & Co's Cardinal Health position peaked at $81K in Q1 2015.
  • 713 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.